Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for down syndrome

Developmental Dynamics

Volumn 239, Issue 6, 2010, Pages 1645-1653

  Blazek, Joshua D ^a   Billingsley, Cherie N ^a   Newbauer, Abby ^a   Roper, Randall J ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Developmental delay; Down syndrome; Embryonic development; Mouse models; Trisomy

Indexed keywords

ALLELE; ARTICLE; ATTENUATION; CONTROLLED STUDY; DOWN SYNDROME; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENETIC DIFFERENCE; GENETIC LINKAGE; HOMOZYGOSITY; MARKER CHROMOSOME; MOUSE; NONHUMAN; PHENOTYPE; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROGENY; ANIMAL; ANIMAL EMBRYO; C57BL MOUSE; GENETICS; TRANSGENIC MOUSE; TRISOMY;

ANIMALS; DOWN SYNDROME; EMBRYO, MAMMALIAN; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHENOTYPE; TRISOMY;

EID: 77952719225     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.22295     Document Type: Article

References (47)

1. Arron JR, Winslow MM, Polleri A, Chang CP, Wu H, Gao X, Neilson JR, Chen L, Heit JJ, Kim SK, Yamasaki N, Miyakawa T, Francke U, Graef IA, Crabtree GR. 2006. NFAT dysregulation by increased dosage of DSCR1 and DY RK1A on chromosome 21. Nature 441: 595-600. (Pubitemid 43927286)
2. Baxter LL, Moran TH, Richtsmeier JT, Troncoso J, Reeves RH. 2000. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Hum Mol Genet 9: 195-202. (Pubitemid 30052743)
3. Bowes C, Li T, Frankel WN, Danciger M, Coffin JM, Applebury ML, Farber DB. 1993. Localization of a retroviral element within the rd gene coding for the beta subunit of cGMP phosphodiesterase. Proc Natl Acad SciUS A 90:2955-2959. (Pubitemid 23113536)
4. Brown SD, Zurakowski D, Rodriguez DP, Dunning PS, Hurley RJ, Taylor GA. 2006. Ultrasound diagnosis of mouse pregnancy and gestational staging. Comp Med 56:262-271. (Pubitemid 44299967)
5. Centers for Disease Control and Prevention. 2006. Improved national prevalence estimates for 18 selected major birth defects - United States, 1999-2001. MMWR Morb Mortal Wkly Rep 54: 1301-1305.
6. Chakrabarti L, Galdzicki Z, Haydar TF. 2007. Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndrome. J Neurosci 27:11483-11495. (Pubitemid 350006912)
7. Chen YJ, Fang PC. 2005. Sensory evoked potentials in infants with Down syndrome. Acta Paediatr 94:1615-1618. (Pubitemid 41754316)
8. Christianson A, Howson CP, Modell B. 2006. March of Dimes global report on birth defects: the hidden toll of dying and disabled children. White Plains, NY: March of Dimes Birth Defects Foundation. p 1-98.
9. Cleves MA, Hobbs CA, Cleves PA, Tilford JM, Bird TM, Robbins JM. 2007. Congenital defects among liveborn infants with Down syndrome. Birth Defects Res A Clin Mol Teratol 79:657-663. (Pubitemid 47502792)
10. Contestabile A, Fila T, Ceccarelli C, Bonasoni P, Bonapace L, Santini D, Bartesaghi R, Ciani E. 2007. Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice. Hippocampus 17:665-678. (Pubitemid 47292037)
11. Contestabile A, Fila T, Cappellini A, Bartesaghi R, Ciani E. 2009. Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome. Cell Prolif 42:171-181.
12. Cook MN, Williams RW, Flaherty L. 2001. Anxiety-related behaviors in the elevated zero-maze are affected by genetic factors and retinal degeneration. Behav Neurosci 115:468-476. (Pubitemid 32378175)
13. Costa AC, Stasko MR, Schmidt C, Davisson MT. 2010. Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pde6b(rd1). Behav Brain Res 206: 52-62.
14. Driscoll DA, Gross S. 2009. Clinical practice. Prenatal screening for aneuploidy. N Engl J Med 360:2556-2562.
15. Epstein CJ. 2001. Down Syndrome (Trisomy 21). In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill. p 1223-1256.
16. Fan Y, Nikitina T, Morin-Kensicki EM, Zhao J, Magnuson TR, Woodcock CL, Skoultchi AI. 2003. H1 linker histones are essential for mouse development and affect nucleosome spacing in vivo. Mol Cell Biol 23:4559-4572. (Pubitemid 36734746)
17. Gardiner K, Fortna A, Bechtel L, Davisson MT. 2003. Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. Gene 318: 137-147. (Pubitemid 37338399)
18. Guihard-Costa AM, Khung S, Delbecque K, Menez F, Delezoide AL. 2006. Biometry of face and brain in fetuses with trisomy 21. Pediatr Res 59:33-38. (Pubitemid 43754451)
19. Hattori M, Fujiyama A, Sakaki Y. 2001. [The DNA sequence of human chromosome 21]. Tanpakushitsu Kakusan Koso 46:2254-2261.
20. Hoelter SM, Dalke C, Kallnik M, Becker L, Horsch M, Schrewe A, Favor J, Klopstock T, Beckers J, Ivandic B, Gailus-Durner V, Fuchs H, Hrabe de Angelis M, Graw J, Wurst W. 2008. "Sighted C3H" mice - a tool for analysing the influence of vision on mouse behaviour? Front Biosci 13:5810-5823.
21. Holtzman DM, Santucci D, Kilbridge J, Chua-Couzens J, Fontana DJ, Daniels SE, Johnson RM, Chen K, Sun Y, Carlson E, Alleva E, Epstein CJ, Mobley WC. 1996. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc Natl Acad Sci USA 93:13333-13338. (Pubitemid 26382816)
22. Kauffman MH. 1992. The atlas of mouse development. San Diego: Elsevier Academic Press. 525 p.
23. Kaufman M, Bard J. 1999. The anatomical basis of mouse development. San Diego: Academic Press.
24. Leonard S, Bower C, Petterson B, Leonard H. 2000. Survival of infants born with Down's syndrome: 1980-96. Paediatr Perinat Epidemiol 14:163-171. (Pubitemid 30199252)
25. Lorenzi H, Duvall N, Cherry SM, Reeves RH, Roper RJ. 2010. PCR prescreen for genotyping the Ts65Dn mouse model of Down syndrome. Biotechniques 48: 35-38.
26. Moore CS. 2006. Postnatal lethality and cardiac anomalies in the Ts65Dn Down syndrome mouse model. Mamm Genome 17:1005-1012. (Pubitemid 44537042)
27. Moore CS, Roper RJ. 2007. The power of comparative and developmental studies for mouse models of Down syndrome. Mamm Genome 18:431-443. (Pubitemid 47360417)
28. Moore CS, Lee JS, Birren B, Stetten G, Baxter LL, Reeves RH. 1999. Integration of cytogenetic with recombinational and physical maps of mouse chromosome 16. Genomics 59:1-5. (Pubitemid 29339866)
29. Mouton PR. 2002. Principles and practices of unbiased stereology: an introduction for bioscientists. Baltimore: Johns Hopkins University Press.
30. Mu J, Slevin JC, Qu D, McCormick S, Adamson SL. 2008. In vivo quantification of embryonic and placental growth during gestation in mice using micro-ultrasound. Reprod Biol Endocrinol 6:34.
31. Nadel L. 2003. Down's syndrome: a genetic disorder in biobehavioral perspective. Genes Brain Behav 2:156-166. (Pubitemid 36898802)
32. Patterson D. 2009. Molecular genetic analysis of Down syndrome. Hum Genet 126:195-214.
33. Paz-Miguel JE, Pardo-Manuel de Villena F, Sanchez-Velasco P, Leyva-Cobian F. 2001. H2-haplotype-dependent unequal transmission of the 17(16) translocation chromosome from Ts65Dn females. Mamm Genome 12:83-85. (Pubitemid 32127976)
34. Pinter JD, Eliez S, Schmitt JE, Capone GT, Reiss AL. 2001. Neuroanatomy of Down's syndrome: a high-resolution MRI study. AmJ Psychiatry 158:1659-1665. (Pubitemid 32923659)
35. Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, Sisodia SS, Schmidt C, Bronson RT, Davisson MT. 1995. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet 11:177-184.
36. Roper RJ, Reeves RH. 2006. Understanding the basis for Down syndrome phenotypes. PLoS Genet 2:e50.
37. Roper RJ, St John HK, Philip J, Lawler A, Reeves RH. 2006. Perinatal loss of Ts65Dn Down syndrome mice. Genetics 172:437-443. (Pubitemid 43345504)
38. Roper RJ, VanHorn JF, Cain CC, Reeves RH. 2009. A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog. Mech Dev 126:212-219.
39. Schieve LA, Boulet SL, Boyle C, Rasmussen SA, Schendel D. 2009. Health of children 3 to 17 years of age with Down syndrome in the 1997-2005 national health interview survey. Pediatrics 123: e253-260.
40. Smith M. 2006. Mental retardation and developmental delay. New York: Oxford University Press.
41. Spencer K. 2001. What is the true fetal loss rate in pregnancies affected by trisomy 21 and how does this influence whether first trimester detection rates are superior to those in the second trimester? Prenat Diagn 21:788-789.
42. Van Cleve SN, Cohen WI. 2006. Part I: clinical practice guidelines for children with Down syndrome from birth to 12 years. J Pediatr Health Care 20:47-54. (Pubitemid 43052691)
43. Van Cleve SN, Cannon S, Cohen WI. 2006. Part II: Clinical Practice Guidelines for adolescents and young adults with Down Syndrome: 12 to 21 Years. J Pediatr Health Care 20:198-205. (Pubitemid 43637049)
44. Vicari S. 2006. Motor development and neuropsychological patterns in persons with Down syndrome. Behav Genet 36: 355-364. (Pubitemid 43876775)
45. Weijerman ME, van Furth AM, Vonk Noordegraaf A, van Wouwe JP, Broers CJ, Gemke RJ. 2008. Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study. J Pediatr 152:15-19. (Pubitemid 350265948)
46. Williams AD, Mjaatvedt CH, Moore CS. 2008. Characterization of the cardiac phenotype in neonatal Ts65Dn mice. Dev Dyn 237:426-435.
47. Wiseman FK, Alford KA, Tybulewicz VL, Fisher EM. 2009. Down syndrome - recent progress and future prospects. Hum Mol Genet 18:R75-R83.